Napredna pretraga

Pregled bibliografske jedinice broj: 36834

Expression of biologically active atrial natriuretic factor following intrahepatic injection of a replication-defective adenoviral vector in dogs


Chetboul, Valerie; Adam, Micheline; Deprez, Isabelle; Ambriović-Ristov, Andreja; Rosenberg, Dan; Crespeau, Francois; Saana, Moez; Pham, Isabelle; Eloit, Marc; Adnot, Serge; Pouchelon, Jean-Louis
Expression of biologically active atrial natriuretic factor following intrahepatic injection of a replication-defective adenoviral vector in dogs // Human gene therapy, 10 (1999), 2; 281-290 (međunarodna recenzija, članak, znanstveni)


Naslov
Expression of biologically active atrial natriuretic factor following intrahepatic injection of a replication-defective adenoviral vector in dogs

Autori
Chetboul, Valerie ; Adam, Micheline ; Deprez, Isabelle ; Ambriović-Ristov, Andreja ; Rosenberg, Dan ; Crespeau, Francois ; Saana, Moez ; Pham, Isabelle ; Eloit, Marc ; Adnot, Serge ; Pouchelon, Jean-Louis

Izvornik
Human gene therapy (1043-0342) 10 (1999), 2; 281-290

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Adenovirus; atrial natriuretic factor; intrahepatic injection

Sažetak
Atrial natriuretic factor (ANF) is a potent natriuretic, diuretic, and vasoactive hormone produced and released by atrial cardiomyocytes, We investigated whether adenovirus-mediated ANF gene delivery to dogs leads to a sustained increase in circulating ANF levels resulting in long-lasting biological effects. An adenoviral vector containing the canine ANF cDNA under the control of the Rous sarcoma virus 3' long terminal repeat (AdRSV-ANF) was injected via the intrahepatic route to nonvaccinated 2-month-old dogs. In the first group of four dogs injected with AdRSV-ANF (10(10.2) TCID50), a short-lived increase in plasma ANF concentrations not associated with biological effects occurred 8-10 days after the injection, as compared with four control dogs injected with an adenovirus encoding a luciferase reporter gene (AdRSV-luc), In a second series of experiments, six dogs received AdRSV-ANF at a dose of 10(10) TCID50 and a replication-defective type 5 adenovirus harboring a modified VAI gene (Ad-VAr) at the same dose. Sustained increases in plasma ANF concentrations and urinary cGMP excretion starting on day 2 and persisting until day 20 were seen, as well as concomitant elevations in natriuresis and diuresis, a transient increase in cardiac output, and a delay in body weight gain, as compared with control dogs injected with AdRSV-luc/Ad-VAr. These results show that adenovirus-mediated ANF gene expression can lead to systemic biological effects in dogs, a finding of potential relevance for the treatment of cardiovascular diseases and sodium-retaining disorders.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Projekt / tema
00981008

Ustanove
Institut "Ruđer Bošković", Zagreb

Autor s matičnim brojem:
Andreja Ambriović Ristov, (173311)

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE